On an investment spree with billions of dollars’ worth of projects ongoing globally, Indianapolis-based Eli Lilly and Company ...
Eli Lilly will spend $3 billion expanding ... add 750 workers to the current tally of 100 at the plant. The expanded facility will focus on manufacturing "injectable medicines, device assembly ...
(Reuters) - Eli Lilly (LLY) said on Thursday it will invest $3 billion to expand the manufacturing plant it bought in Pleasant Prairie, Wisconsin earlier this year, as it scrambles to meet soaring ...
Eli Lilly is experiencing explosive growth thanks to its diabetes and obesity treatments. Beyond weight loss, the company is quietly building a fast-growing oncology business. This is an enormous ...
Medical industry giants Eli Lilly and Merck will collaborate with Purdue through a new institute, which aims to advance ...
Eli Lilly and Merck & Co. are partnering with Purdue University to launch the Young Institute Pharmaceutical Manufacturing Consortium aimed at pioneering new advances in how medicines are produced.
During the shortage, some 503B compounding pharmacies began manufacturing and marketing knockoff versions of the medications, according to the Jan. 1 motion. Eli Lilly has invested billions of ...
Eli Lilly is spending another $3 billion to bulk up manufacturing as the drugmaker seeks to stoke production of some blockbuster drugs and future products. Lilly said Thursday it will expand a ...
Eli Lilly (LLY ... to make progress on our manufacturing build-out, and U.S. supply across all doses of tirzepatide was available throughout Q4," said Lilly CEO David Ricks in a statement.
Sales of Eli Lilly's lead drug, tirzepatide, which it markets as Zepbound for weight loss and Mounjaro for diabetes, leapt up to a combined $5.4 billion in the fourth quarter. That's some amazing ...
CEO Dave Ricks told CNBC that the company has "tons of supply coming online" and that it will add more manufacturing capacity. Eli Lilly cut its revenue guidance on Tuesday as it said demand for ...
As expected by many, Eli ... highlights Lilly’s “direct, substantial, legally protectable interest in the proceedings” as it has invested over $23 billion to increase its manufacturing ...